NO20034273L - Steroidforbindelser, anvendelse av disse forbindelsene til fremstilling avmeioseregulerende medikamenter og fremgangsmåte for fremstillingav disse forbindelsene - Google Patents

Steroidforbindelser, anvendelse av disse forbindelsene til fremstilling avmeioseregulerende medikamenter og fremgangsmåte for fremstillingav disse forbindelsene

Info

Publication number
NO20034273L
NO20034273L NO20034273A NO20034273A NO20034273L NO 20034273 L NO20034273 L NO 20034273L NO 20034273 A NO20034273 A NO 20034273A NO 20034273 A NO20034273 A NO 20034273A NO 20034273 L NO20034273 L NO 20034273L
Authority
NO
Norway
Prior art keywords
compounds
regulators
medicinal
preparing
preparation
Prior art date
Application number
NO20034273A
Other languages
English (en)
Other versions
NO20034273D0 (no
Inventor
Thorsten Blume
Peter Esperling
Christa Hegele-Hartung
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20034273D0 publication Critical patent/NO20034273D0/no
Publication of NO20034273L publication Critical patent/NO20034273L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20034273A 2001-03-26 2003-09-25 Steroidforbindelser, anvendelse av disse forbindelsene til fremstilling avmeioseregulerende medikamenter og fremgangsmåte for fremstillingav disse forbindelsene NO20034273L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01250108A EP1245572A1 (en) 2001-03-26 2001-03-26 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
PCT/EP2002/003148 WO2002079220A2 (en) 2001-03-26 2002-03-20 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation

Publications (2)

Publication Number Publication Date
NO20034273D0 NO20034273D0 (no) 2003-09-25
NO20034273L true NO20034273L (no) 2003-11-25

Family

ID=8181575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034273A NO20034273L (no) 2001-03-26 2003-09-25 Steroidforbindelser, anvendelse av disse forbindelsene til fremstilling avmeioseregulerende medikamenter og fremgangsmåte for fremstillingav disse forbindelsene

Country Status (19)

Country Link
US (1) US6916921B2 (no)
EP (2) EP1245572A1 (no)
JP (1) JP2004534011A (no)
KR (1) KR20030088043A (no)
CN (1) CN1332975C (no)
AU (1) AU2002315260B2 (no)
BR (1) BR0208381A (no)
CA (1) CA2438210A1 (no)
CZ (1) CZ20032578A3 (no)
HK (1) HK1070900A1 (no)
HU (1) HUP0303643A2 (no)
IL (1) IL157272A0 (no)
MX (1) MXPA03008199A (no)
NO (1) NO20034273L (no)
PL (1) PL369576A1 (no)
RU (1) RU2289587C2 (no)
UA (1) UA75130C2 (no)
WO (1) WO2002079220A2 (no)
ZA (1) ZA200308271B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1514874A1 (en) * 2003-07-28 2005-03-16 Schering Aktiengesellschaft Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof
KR100689260B1 (ko) * 2005-05-24 2007-03-02 삼원산업주식회사 항산화성 스틸벤계 형광증백제 및 이의 합성방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1095167A (en) * 1963-12-05 1967-12-13 Shalom Sarel Amino-steroids
US3419661A (en) * 1964-01-13 1968-12-31 Univ Missouri Oral contraceptive for birds
DE1643004A1 (de) * 1967-02-07 1971-04-08 Schering Ag Bisnorcholenderivate und Verfahren zu ihrer Herstellung
DE1930473A1 (de) * 1969-06-14 1970-12-17 Schering Ag 22-N-substituierte (20R)-23,24-dinor-cholanderivate
US5716777A (en) 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
RU2188006C2 (ru) * 1995-03-06 2002-08-27 Ново Нордиск А/С Стимуляция мейоза
PL185622B1 (pl) 1995-06-23 2003-06-30 Novo Nordisk As Zastosowanie związku steroidowego i sposób regulacji mejozy w komórce rozrodczej ssaka
EP0946584B1 (en) 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
JP2003522728A (ja) * 1998-05-13 2003-07-29 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
EP1098652A2 (en) 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
ATE317266T1 (de) 1999-02-24 2006-02-15 Novo Nordisk As In vitro methode zur synchronisation von oozytenreifung
ATE361091T1 (de) 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit
CZ20012671A3 (cs) 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
IL148234A0 (en) 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
AU3376501A (en) 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
US6988613B2 (en) * 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
WO2002062287A1 (en) * 2001-02-06 2002-08-15 Novo Nordisk A/S Process and container with low oxygen content and further containing mas

Also Published As

Publication number Publication date
HUP0303643A2 (hu) 2004-03-01
WO2002079220A2 (en) 2002-10-10
MXPA03008199A (es) 2004-01-29
CZ20032578A3 (cs) 2003-12-17
NO20034273D0 (no) 2003-09-25
WO2002079220A3 (en) 2003-10-16
BR0208381A (pt) 2004-06-15
ZA200308271B (en) 2005-01-24
CA2438210A1 (en) 2002-10-10
HK1070900A1 (en) 2005-06-30
CN1543473A (zh) 2004-11-03
US20020188143A1 (en) 2002-12-12
JP2004534011A (ja) 2004-11-11
IL157272A0 (en) 2004-02-19
CN1332975C (zh) 2007-08-22
RU2003130228A (ru) 2005-04-10
RU2289587C2 (ru) 2006-12-20
AU2002315260B2 (en) 2008-04-03
EP1245572A1 (en) 2002-10-02
US6916921B2 (en) 2005-07-12
KR20030088043A (ko) 2003-11-15
UA75130C2 (en) 2006-03-15
EP1401856A2 (en) 2004-03-31
PL369576A1 (en) 2005-05-02

Similar Documents

Publication Publication Date Title
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
NO20041277L (no) Farmasoytiske preparater for behandling av astma.
NO20030870D0 (no) Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav
IL152254A0 (en) Devices for physiological fluid sampling and methods of using the same
EP1572890A4 (en) SLC7S AS MODULATORS OF THE P53 PATH AND METHOD OF USE
DE60208622D1 (de) Siliciumoxidpulver und dessen Herstellung
NO20024925L (no) Flerbruks-kirurgisk sementdispenserapparat og utrustning for samme
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DK1448591T3 (da) 17-alpha-alkyl-17-beta-oxy-estratriener og mellemprodukter til fremstilling heraf, anvendelse af 17-alpha-alkyl-17-beta-oxy-estratriener til fremstilling af lægemidler samt farmaceutiske præparater
DK2206702T3 (da) Bicyklisk forbindelse, fremstilling og anvendelse deraf
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
IL158693A0 (en) Azole compounds, process for preparation of the same and use thereof
IS6964A (is) Ónæmismeðferðarsamsetningar til meðhöndlunar á æxlum sem oftjá ganglíósíð
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20035540D0 (no) Eksoterme preparater til behandling av ektoparasitter
NO20033506L (no) Parasitticidale preparater og metoder for anvendelse
GB0127832D0 (en) Method for the preparation of pharmaceutical nanosuspensions
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1353912T3 (da) 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
AU2002337843A8 (en) Processes for the preparation of substituted isoxazoles and 2-isoxazolines
NO20034273L (no) Steroidforbindelser, anvendelse av disse forbindelsene til fremstilling avmeioseregulerende medikamenter og fremgangsmåte for fremstillingav disse forbindelsene
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
DK1241169T3 (da) Isoindoloindolonforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application